Who owns REGENTIS BIOMATERIALS LTD?
- Ticker: RGNT
- CUSIP Number: m8211g108
Tip: Access positions for across all investors
Analyze quarterly positions in Regentis Biomaterials with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Regentis Biomaterials stock
Who bought or sold REGENTIS BIOMATERIALS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Rosalind Advisors | 702k | $2.5M | 179% | Jun 2026 |
|
| Warberg Asset Management | 87k | $306k | 100% | Jun 2026 |
|
| Jane Street | 43k | $153k | 100% | Jun 2026 |
|
| Renaissance Technologies | 13k | $47k | 100% | Jun 2026 |
|
| UBS Group | 434.00 | $1.5k | 30% | Jun 2026 |
|
| Tower Research Capital | 11.00 | $39.000500 | 100% | Jun 2026 |
|
Who sold out of Regentis Biomaterials?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| AIGH Capital Management | Mar 2026 | 300k | $917k |